Table 1.
Year | Study | Comparator groups |
Number of subjects (N) |
Study design | Summary of significant findings |
Reference |
---|---|---|---|---|---|---|
| ||||||
1997 | Bruunsgaard et al | Eccentric vs. concentric exercise | 9 | Randomized control trial | IL-6 increased after eccentric exercise. | 34 |
| ||||||
1998 | Ostrowski et al. | Pre- and postintense prolonged exercise | 16 | Randomized control trail | IL-6 increased post exercise: | 35 |
Pre: 1.5 ± 0.7 pg/mL | ||||||
Post: 94.4 ± 12.6 pg/mL | ||||||
| ||||||
2005 | Stürmer et al. | Acute LBP/cLBP: low vs. high pain | 72 (41 chronic, 31 acute) | Longitudinal – prospective | Acute LBP: increasing CRP with increasing pain (CRP: 1.6× higher in high-pain group). | 26 |
| ||||||
2006 | Gebhardt et al. | Acute LBP cLBP | 72 (41 chronic, 32 acute) | Longitudinal – prospective | Lower CRP with decreasing pain in acute LBP | 27 |
| ||||||
2007 | Rannou et al. | Modic 0, I, II changes | 85 | Cross-sectional – prospective | Serum hsCRP higher in modic I than 0 or II | 42 |
| ||||||
2007 | Uçeyler et al. | Painless vs. painful neuropathy | 32 painful, 20 painless, 38 healthy control | Cross-sectional – prospective | Painful group had 2× higher blood IL-2 and TNF-α mRNA levels than painless and control groups; | 37 |
IL-10 mRNA levels 2× higher in painless group than painful. | ||||||
| ||||||
2008 | Wang et al. | Chronic LBP and control | 120 per group | Longitudinal – prospective | Higher proportion of chronic LBP patients had TNF-α level higher than 2 pg/mL as compared with controls | 45 |
| ||||||
2010 | Wang et al. | Chronic LBP and control | 29 per group | Cross-sectional – prospective | TNF-α levels were 25× higher in cLBP than controls. | 46 |
| ||||||
2011 | Park & Lee | Pre- vs. posttreatment with ESI | 55 | Cross-sectional – prospective | No correlation between hsCRP and VAS; | 44 |
hsCRP reduced posttreatment compared with pretreatment. | ||||||
| ||||||
2012 | Goode et al. | Graded scale of disc space narrowing (DSN), osteophyte formation (OST) in patients with and without LBP symptoms | 547 | Retrospective | Type 11 collagen (C2C) was associated with DSN; | 61 |
COMP was associated with DSN among patientss. with symptoms; | ||||||
HA and C2C are correlated with DSN severity. | ||||||
| ||||||
2012 | Licciardone et al. | Undefined chronic LBP by pain severity and number of osteopathic lesions | 70 | Substudy nested within random control trial | IL-6 and IL-1β correlated with number of osteopathic lesions; | 39 |
IL-6 correlated with LBP severity. | ||||||
| ||||||
2014 | Luchting et al. | Chronic LBP vs. controls | 10 | Cross-sectional – prospective | Increased frequency of Treg cells in CLBP patients compared with controls; | 48 |
decreased frequency of TH17 in cLBP compared with controls. | ||||||
| ||||||
2014 | Rathod et al. | Lumbar disc disease undergoing surgery and controls | 50 lumbar, 50 control | Longitudinal – prospective | hsCRP almost 30× higher in lumbar disc disease patients compared with controls | 43 |
| ||||||
2014 | Sowa et al. | Before vs. after exercise | 43 | Cross sectional – prospective | RANTES correlated with pain and pain-related function after activity | 47 |
| ||||||
2016 | de Queiroz et al. | Acute LBP by pain and disability | 155 | retrospective | Positive correlations: | 32 |
TNF-α and pain severity; | ||||||
IL-6 and pain severity | ||||||
| ||||||
2016 | Deng et al. | DH vs. control | 10 | Cross-sectional – prospective | IL-6 higher in DH than controls; | 78 |
Col II and aggrecan lower in DH than controls. | ||||||
| ||||||
2016 | Grad et al. | Degenerated vs nondegenerated | 80 | Case control – prospective | CCL5 was 1.6× higher in degenerated group compared with nondegenerated controls; | 77 |
CXCL6 was 1.3× higher in degenerated group compared with controls | ||||||
| ||||||
2016 | Wang et al. | Severe vs. mild sciatica | 58 severe, 50 mild, 30 healthy control | Cross sectional – prospective | IL-6: 1.5× higher in severe than mild or control; | 38 |
IL-8: higher in severe than control; | ||||||
TNF-a: 2× higher in severe than mild or control; | ||||||
IL-4: 2× higher in mild than severe or control; | ||||||
IL-6: TNF-αa, IL-10 correlated with ODI |